IP Library Granted Patent US 7,439,270
Granted Patent B2
US 7,439,270 · App. 11/422,788 · Granted Oct 21, 2008

Drugs for spinal anesthesia

Assignee: Univeristy of Iowa Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,439,270
App. No.
11/422,788
Granted
Oct 21, 2008
Kind
B2
Abstract

Spinal anesthetics for intrathecal administration to produce spinal anesthesia are provided with use of 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid or its pharmaceutically active analogues.

Claims (9)

1. A method of inducing spinal anesthesia, comprising:

administering spinally an anesthesia producing effective amount of 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid to a patient in need of spinal anesthetic.

2. The method of claim 1 wherein the administering spinally is by intrathecal administration.

3. The method of claim 1 wherein the 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid is administered in conjunction with a pharmaceutically acceptable carrier.

4. The method of claim 2 wherein the 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid is administered in conjunction with a pharmaceutically acceptable carrier.

5. The method of claim 1 wherein the amount of 6-[2-(1(2)H -tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid administered is from 0.1 mg to 3.0 mg.

6. The method of claim 1 wherein the amount of 6-[2-(1(2)H -tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid administered is from 0.5 mg to 2.0 mg.

7. The method of claim 1 wherein the 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoqui nolone-3-carboxylic acid is LY293558 ((3S,4aR,6R,8aR)6- [2-1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid).

8. The method of claim 2 wherein the 6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid is LY293558 ((3S,4aR,6R,8aR)6- [2-1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinolone-3-carboxylic acid).

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 2, 2020
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 054512/0836 →
CONFIRMATORY LICENSE Recorded Mar 18, 2009
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022408/0693 →
CONFIRMATORY LICENSE Recorded Oct 3, 2008
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021633/0354 →
Continuity (2)
Continuation 1003363200 · Dec 26, 2001
Related Publication 20070037847A1 · Feb 15, 2007